Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

5.250 -0.140 (-2.60%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
30 31 Next >
News headline image
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45 
Via Benzinga
News headline image
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company ↗
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 24, 2022 ↗
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61 
Via Benzinga
News headline image
Cybin, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68 
Via Benzinga
News headline image
Compass Pathways: Q1 Earnings Insights ↗
Compass Pathways (NASDAQ:CMPS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology ↗
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
News headline image
Can Psilocybin Help With Treatment-Resistant Depression? COMPASS Pathways Study Shows Promising Results ↗
COMPASS Pathways plc (NASDAQ: CMPS), a mental health care company, presented positive data from the randomized, controlled, double-blind study of psilocybin therapy, at the American Psychiatric... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 20, 2022 ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77 
Via Benzinga
News headline image
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say ↗
Patents are the golden eggs of the booming psychedelic space. 
Via Benzinga
News headline image
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29 
Via Benzinga
News headline image
Cybin, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55 
Via Benzinga
News headline image
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32 
Via Benzinga
News headline image
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 16, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
News headline image
Psychedelic Compounds-Based Stocks Index Imploding ↗
Our index of Psychedelic Compounds-Based Drug Stocks tracks clinical-stage startups still in R&D is down 60% YTD; -78% from its 2021 high. 
Via Talk Markets
News headline image
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 12, 2022 ↗
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06 
Via Benzinga
Compass Pathways Research Suggests Psilocybin Can Treat Anorexia
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From May 11, 2022 ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS: 
Via Benzinga
News headline image
Compass Pathways Reports Q1 Financial Results, With Increased R&D Expenses Compared To 2021 ↗
Compass Pathways (NASDAQ: CMPS) announced its financial results for the first quarter of 2022, which ended March 31. Q1 Results For the first three months of the year, net loss was $21.2 million, or... 
Via Benzinga
News headline image
Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26 
Via Benzinga
News headline image
Psyched: Protesters At DEA HQ Demand Access To Psychedelics, Connecticut Approves Budget Bill With MDMA & Psilocybin Programs ↗
Psychedelics policy action took center stage this week. 
Via Benzinga
News headline image
EXCLUSIVE: Kevin Harrington Becomes The Latest 'Shark Tank' Judge To Enter The Psychedelics Space ↗
The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrington, one of the original “sharks” in ABC's “Shark Tank”... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From May 9, 2022 ↗
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34 
Via Benzinga
News headline image
A Preview Of Compass Pathways's Earnings ↗
Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Compass... 
Via Benzinga
News headline image
New Study To Evaluate Magic Mushroom's Therapeutic Potential On Autistic Adults ↗
Psychedelics continue to garner attention as possible treatments for diverse mental health conditions. Now, Compass Pathways (NASDAQ: CMPS) will undertake a study to evaluate psilocybin’s effects on... 
Via Benzinga
News headline image
Psychedelic Stocks Continue To Decline In May ↗
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue. 
Via Talk Markets
News headline image
TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16 
Via Benzinga
News headline image
GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS: 
Via Benzinga
News headline image
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.